about
T cell receptor mimic antibodies for cancer therapyLung cancer vaccinesTumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data.Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analyses.Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia.Tumor microenvironment and immune effects of antineoplastic therapy in lymphoproliferative syndromes.Sperm fibrous sheath proteins: a potential new class of target antigens for use in human therapeutic cancer vaccines.Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic moleculeImproved antigen cross-presentation by polyethyleneimine-based nanoparticles.The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Clonal cytotoxic T cells in myeloma.Poxvirus vaccines for cancer and HIV therapy.Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.Current advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma.Dendritic cell-based immunotherapy for malignant gliomas.Tracking the migration of dendritic cells by in vivo optical imaging.Adenovirus as vehicle for anticancer genetic immunotherapy.Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.Enhancement of anti-tumor effect of particulate vaccine delivery system by 'bacteriomimetic' CpG functionalization of poly-lactic-co-glycolic acid nanoparticlesA mathematical model of the enhancement of tumor vaccine efficacy by immunotherapy.Targeted agents in non-small cell lung cancer therapy: What is there on the horizon?Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue.Antigen-presenting particle technology using inactivated surface-engineered viruses: induction of immune responses against infectious agents.Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
P2860
Q26768271-E937CB7F-3C95-49FE-AF41-13C1AA136DF2Q27014375-385E0D45-A3AF-4314-A2FF-D04286A1509BQ33662452-A90255D5-85E8-4F50-B14A-2FAD1EE9553DQ33735322-3995E07B-14B3-4831-BB6D-41A835B6F718Q33783092-EC90433B-5C58-4FA6-8D35-A36E5B096E69Q34097414-82135B2A-3529-422D-8C4E-3E08EC1573AFQ34111850-E9C8DA42-2561-42AD-B15E-6B9823B4049CQ34173426-611AAFDA-BAE4-47EA-B0CF-80FC57C713B7Q34513978-4132B550-B1B2-474F-AA17-4D4DFEBC679BQ35052176-B95368BB-049E-4466-A748-23C47A669BE5Q35142329-F67F7EC3-150A-4C39-B83E-B0D9392AF2BFQ35614630-485C8F0A-AC9F-4EAE-9767-381C46DC8E92Q35753546-456403B1-321A-4148-8791-1894D48DDCD0Q35778581-53EB9742-DF78-43AA-A1F6-27C293A526AAQ36194606-01B3D6E4-FF6A-4D7C-BD48-5F958709BAD0Q36198607-11FD3426-CBC1-4808-8DA0-4767D5765B9CQ36259652-F3EBB8A9-1F52-4C5B-B525-273189EA0727Q36288930-A71B0452-B5F1-4AD6-A521-8FD274E64AF0Q36445546-8074D641-53AA-4C60-A434-2E4F09273935Q36822999-DE999AEB-69A1-4A1E-9976-8D7391F833D0Q37293334-38672015-35A4-4954-B88C-E8372ED39F43Q38100162-307142D7-212C-4A1F-B35F-28036CFB982CQ39886839-896BA189-EF5C-43A5-9E44-B7DF3A803896Q41871158-78221830-C7B9-45B0-B41E-933AE8AACB94Q42680550-C55E27DE-8CE6-4D0A-8F9F-5C5194C2BD54
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cancer vaccines and immunotherapy.
@ast
Cancer vaccines and immunotherapy.
@en
Cancer vaccines and immunotherapy.
@nl
type
label
Cancer vaccines and immunotherapy.
@ast
Cancer vaccines and immunotherapy.
@en
Cancer vaccines and immunotherapy.
@nl
prefLabel
Cancer vaccines and immunotherapy.
@ast
Cancer vaccines and immunotherapy.
@en
Cancer vaccines and immunotherapy.
@nl
P2093
P356
P1476
Cancer vaccines and immunotherapy.
@en
P2093
Anne Armstrong
Peter L Stern
Robert E Hawkins
Said Dermime
P304
P356
10.1093/BMB/62.1.149
P577
2002-01-01T00:00:00Z